may be if wesfarmers bid for Lynas fails, which the board has rejected today, they could be interested. Left field I know, but, you never know
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025